155 related articles for article (PubMed ID: 4138537)
1. Binding of rifampicin by human plasma proteins.
Boman G; Ringberger VA
Eur J Clin Pharmacol; 1974 Aug; 7(5):369-73. PubMed ID: 4138537
[No Abstract] [Full Text] [Related]
2. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
Reutgen H
Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
[No Abstract] [Full Text] [Related]
3. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Mkrtchian SV; Ushkin VV
Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
[No Abstract] [Full Text] [Related]
4. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
[No Abstract] [Full Text] [Related]
5. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
6. Relationship between lipid composition and antibiotic-resistance to isoniazid, streptomycin, p-aminosalicylic acid, ethambutol, rifampicin in mycobacteria.
Alberghina M
Ital J Biochem; 1976; 25(2):127-51. PubMed ID: 962981
[TBL] [Abstract][Full Text] [Related]
7. A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971.
Abbott MR
Med J Aust; 1973 Jun; 1(23):1144-6. PubMed ID: 4199110
[No Abstract] [Full Text] [Related]
8. Protein binding of rifampicin to different individual sera.
Aoyagi T
Scand J Respir Dis Suppl; 1973; 84():44-9. PubMed ID: 4522077
[No Abstract] [Full Text] [Related]
9. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
Hobby GL; Johnson PM; Boytar-Papirnyik V
Am Rev Respir Dis; 1971 Jun; 103(6):842-4. PubMed ID: 4996847
[No Abstract] [Full Text] [Related]
10. In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein.
Woo J; Cheung W; Chan R; Chan HS; Cheng A; Chan K
Clin Biochem; 1996 Apr; 29(2):175-7. PubMed ID: 8601328
[No Abstract] [Full Text] [Related]
11. Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
Raleigh JW; Wichelhausen R
Am Rev Respir Dis; 1973 Sep; 108(3):639-42. PubMed ID: 4200815
[No Abstract] [Full Text] [Related]
12. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. I. Incubating temperature and chemotherapeutic effect].
Maekawa N; Nakanishi M; Kawai M; Ikeda N; Nakai H
Kekkaku; 1971 Jul; 46(7):235-7. PubMed ID: 5000367
[No Abstract] [Full Text] [Related]
13. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
Golychevskaja VI
G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
[No Abstract] [Full Text] [Related]
14. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
Pallanza R; Arioli V; Furesz S; Bolzoni G
Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
[No Abstract] [Full Text] [Related]
15. The binding of antituberculous drugs to normal and kwashiorkor serum.
Buchanan N; van der Walt LA
S Afr Med J; 1977 Sep; 52(13):522-5. PubMed ID: 918794
[TBL] [Abstract][Full Text] [Related]
16. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
Hobby GL; Johnson PM; Boytar-Papirnyik V
Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
[No Abstract] [Full Text] [Related]
17. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
18. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Makarevich NM; Rudoĭ NM
Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
[No Abstract] [Full Text] [Related]
19. Primary drug-resistant Mycobacterium tuberculosis isolated in Massachusetts in 1972.
Stottmeier KD; Burkes J
J Infect Dis; 1974 Sep; 130(3):293-294. PubMed ID: 4213310
[No Abstract] [Full Text] [Related]
20. Morphine binding to human plasma proteins.
Olsen GD
Clin Pharmacol Ther; 1975 Jan; 17(1):31-5. PubMed ID: 47279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
